Announced Mon, 29 Jun · 09:34 IST
Alkem unit updates Occlutech acquisition deal with supplementary agreement
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹5425.00
prior close
₹5507.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.3+0.2-0.4+2.8+2.5+1.4+2.8+3.2+3.6+4.2———
Up moveDown movePending
AI summary
Alkem Laboratories' wholly owned subsidiary Alkem Medtech has signed a First Supplementary Agreement on 26 June 2026 to its earlier Share Purchase Agreement for acquiring 51 percent to 55 percent stake in Switzerland-based Occlutech Holding AG. This amends the original deal signed on 6 March 2026, which was first disclosed to exchanges in February 2026. Occlutech operates in the medtech segment. Further details will be posted on the company's website.
Likely market impact
Progression of the medtech acquisition shows Alkem continuing its international expansion; terms of the deal have now been amended.